Grail Inc. (NASDAQ:GRAL) is one of the best small-cap stocks with huge growth potential. On February 20, Baird cut the price target on Grail Inc. (NASDAQ:GRAL) to $82 from $113 while maintaining an Outperform rating on the shares. The rating update came after the announcement that its NHS study missed its primary endpoint. 15 Healthiest Countries In Africa A healthcare professional wearing a health communications device discussing patient data with a colleague. The same day, Canaccord also cut the price ...